South & Central America Endomyocardial Biopsy Devices Market Size and Forecast (2021

Description

List of Tables

The South and Central America Endomyocardial Biopsy Devices Market is projected to grow from US$ 10,892.3 Thousand in 2025 to US$ 13,256.0 Thousand by 2034. The market is expected to register a CAGR of 2.2% during the forecast period from 2026 to 2034.

Executive Summary and South and Central America Endomyocardial Biopsy Devices Market Analysis

The endomyocardial biopsy devices market across South and Central America is being supported by the growing incidence of cardiovascular diseases, improving access to healthcare services, and increased investment in cardiac care infrastructure. Cardiovascular disorders continue to represent a major cause of mortality in countries such as Brazil, Argentina, Chile, and Colombia, generating greater demand for reliable diagnostic procedures, including endomyocardial biopsy for the assessment of cardiomyopathies and monitoring of transplant patients.

The regulatory environment is also developing across the region. Authorities such as the Brazilian Health Regulatory Agency and Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) are implementing medical device requirements focused on safety while facilitating product commercialization through increasing alignment with international regulatory practices. In parallel, the expansion of private healthcare networks, greater availability of catheterization laboratories, and rising adoption of minimally invasive cardiac procedures are creating favorable conditions for market development.

The presence of major international MedTech companies, including Abbott Laboratories, Medtronic plc, and Boston Scientific Corporation, is improving regional access to advanced biopsy and catheter-based technologies. Furthermore, organizations such as the Inter-American Society of Cardiology are supporting professional training, clinical research, and guideline development. These initiatives are contributing to greater awareness and adoption of advanced cardiac diagnostic technologies throughout South and Central America.

Strategic Insights

South and Central America Endomyocardial Biopsy Devices Market Segmentation Analysis

By Product Type, the South and Central America Endomyocardial Biopsy Devices Market is segmented into Biopsy Forceps and Catheters, Guidance Systems, and Accessories. The Biopsy Forceps and Catheters segment held the dominant market position in 2025.

By Biopsy Forceps and Catheters, the market is divided into Standard Endomyocardial Biopsy Forceps and Flexible Biopsy Catheters. The Standard Endomyocardial Biopsy Forceps segment accounted for the largest share in 2025.

By Guidance Systems, the market is categorized into Fluoroscopy-guided Systems, Echocardiography-guided Systems, and Emerging Robotic Navigation Systems. The Fluoroscopy-guided Systems segment dominated the market in 2025.

By Accessories, the market includes Introducer Sheaths, Guidewires, and Localization Tools. The Introducer Sheaths segment represented the leading share in 2025.

By Guidance Technique, the market is segmented into Fluoroscopy-guided EMB, Echocardiography-guided EMB, and Hybrid Techniques. The Fluoroscopy-guided EMB segment held the largest market share in 2025.

By Application, the market is classified into Transplant Rejection Monitoring, Myocarditis Diagnosis, Cardiomyopathy Evaluation, and Other Cardiac Pathologies. The Transplant Rejection Monitoring segment dominated the market in 2025.

By End User, the South and Central America Endomyocardial Biopsy Devices Market is divided into Cardiac Centers and Hospitals, Diagnostic and Research Institutes, and Academic Institutions. The Cardiac Centers and Hospitals segment held the dominant position in 2025.

Market Report Scope

South and Central America Endomyocardial Biopsy Devices Market Outlook

Cardiac centers, particularly hospitals with high volumes of transplant procedures and advanced heart failure cases, serve as important environments for the clinical development and validation of endomyocardial biopsy technologies. These institutions generate valuable procedural experience, patient data, and clinical evidence that manufacturers can use to improve biopsy systems. Collaborations with experienced interventional cardiologists allow companies to refine catheter flexibility, enhance biopsy forceps designs, and incorporate advanced imaging technologies such as intracardiac echocardiography and fluoroscopy into procedural workflows.

Leading cardiac institutions, including Cleveland Clinic and Massachusetts General Hospital, have collaborated with medical device manufacturers to assess biopsy technologies in complex clinical scenarios. These applications can include post-transplant rejection surveillance and the evaluation of uncommon cardiomyopathies. Such partnerships establish an environment in which feedback from clinicians can be incorporated more rapidly into product development. This iterative process can improve device safety, minimize procedure-related complications such as cardiac perforation, and enhance tissue-sampling performance.

As biopsy procedures become more standardized and supported by clinical evidence, physician confidence and institutional acceptance can increase. This, in turn, encourages broader utilization of EMB technologies across hospitals and creates additional demand for biopsy systems with improved flexibility, precision, safety, and imaging compatibility.

From a commercial and strategic perspective, partnerships between device manufacturers and cardiac centers can also contribute to faster regulatory submissions and broader market expansion. Companies such as Medtronic and Abbott Laboratories participate in collaborative development initiatives with cardiac institutions to evaluate next-generation biopsy catheters under real-world clinical conditions. The resulting clinical evidence can provide important support for regulatory evaluation and commercialization.

Teleflex also works with clinicians to improve its biopsy forceps portfolio by addressing practical challenges identified during clinical procedures. At the same time, emerging companies such as BioCardia are exploring partnerships with specialized cardiac institutions to combine endomyocardial biopsy procedures with regenerative medicine applications. Such initiatives have the potential to extend EMB beyond its traditional diagnostic role.

These collaborations can further incorporate physician training and education programs, with major cardiac centers serving as platforms for disseminating procedural best practices and introducing newer technologies. Consequently, partnerships between manufacturers and specialized cardiac institutions create a mutually beneficial ecosystem in which technologies are clinically evaluated, adoption is accelerated, and additional applications are identified. This represents an important opportunity supporting sustained growth in the global endomyocardial biopsy devices market.

South and Central America Endomyocardial Biopsy Devices Market Country Insights

By country, the South and Central America Endomyocardial Biopsy Devices Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil accounted for the largest market share in 2025.

Brazil represents the largest market for endomyocardial biopsy devices in the region, supported by its substantial cardiovascular disease burden, large patient population, and comparatively developed healthcare infrastructure. Medical device regulation in the country is overseen by the Brazilian Health Regulatory Agency (ANVISA), which applies comprehensive approval and compliance requirements designed to ensure the safety, quality, and effectiveness of medical devices while increasingly incorporating internationally recognized regulatory practices.

Brazil has an extensive network of public and private healthcare institutions, including specialized cardiac facilities capable of performing complex procedures such as heart transplantation. Endomyocardial biopsy plays an important role in monitoring transplant recipients for potential rejection, supporting continued demand for biopsy technologies in specialized cardiac centers.

The country also benefits from academic and clinical support provided by organizations such as the Brazilian Society of Cardiology, which promotes clinical education, professional development, and the adoption of evidence-based cardiac care practices. Major international healthcare technology companies, including GE HealthCare, Siemens Healthineers, and Abbott Laboratories, maintain a significant presence in Brazil and contribute to developments involving catheter-based diagnostic technologies and integration with advanced imaging systems.

Increasing healthcare modernization initiatives and continued expansion of catheterization laboratories are further improving the availability of minimally invasive cardiovascular procedures. These developments are expected to support the gradual adoption of advanced endomyocardial biopsy technologies throughout Brazil.

South and Central America Endomyocardial Biopsy Devices Market Company Profiles

Major companies operating in the South and Central America Endomyocardial Biopsy Devices Market include Terumo Corp, Argon Medical Devices, Koninklijke Philips NV, GE HealthCare Technologies Inc., Siemens Healthineers AG, Cordis Corp, Scholten Surgical Instruments, Inc., Changzhou Lookmed Medical Instrument Co., Ltd., FEHLING INSTRUMENTS GmbH, and WILDmedical GmbH.

Market participants are pursuing strategies such as geographic expansion, product innovation, strategic partnerships, mergers, and acquisitions to strengthen their competitive positions. These initiatives are focused on expanding product offerings, introducing improved biopsy technologies, entering new markets, and responding to changing clinical and healthcare requirements.

Product Code: TIPRE00043897

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Endomyocardial Biopsy Devices Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. South and Central America Endomyocardial Biopsy Devices Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Endomyocardial Biopsy Devices Market - South and Central America Analysis

5.1 South and Central America Endomyocardial Biopsy Devices Market Revenue (US$ Thousand), 2021 - 2034
5.2 South and Central America Endomyocardial Biopsy Devices Market Revenue Forecast and Analysis

6. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Product Type

6.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Product Type
- 6.1.1 Biopsy Forceps and Catheters
  - 6.1.1.1 Overview
  - 6.1.1.2 Biopsy Forceps and Catheters: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 6.1.2 Guidance Systems
  - 6.1.2.1 Overview
  - 6.1.2.2 Guidance Systems: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 6.1.3 Accessories
  - 6.1.3.1 Overview
  - 6.1.3.2 Accessories: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

7. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Biopsy Forceps And Catheters

7.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Biopsy Forceps And Catheters
- 7.1.1 Standard endomyocardial biopsy forceps
  - 7.1.1.1 Overview
  - 7.1.1.2 Standard endomyocardial biopsy forceps: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 7.1.2 Flexible biopsy catheters
  - 7.1.2.1 Overview
  - 7.1.2.2 Flexible biopsy catheters: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

8. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Guidance Systems - Product Type

8.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Guidance Systems - Product Type
- 8.1.1 Fluoroscopy-guided systems
  - 8.1.1.1 Overview
  - 8.1.1.2 Fluoroscopy-guided systems: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 8.1.2 Echocardiography-guided systems
  - 8.1.2.1 Overview
  - 8.1.2.2 Echocardiography-guided systems: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 8.1.3 Emerging robotic navigation systems
  - 8.1.3.1 Overview
  - 8.1.3.2 Emerging robotic navigation systems: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

9. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Accessories

9.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Accessories
- 9.1.1 Introducer sheaths
  - 9.1.1.1 Overview
  - 9.1.1.2 Introducer sheaths: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 9.1.2 Guidewires
  - 9.1.2.1 Overview
  - 9.1.2.2 Guidewires: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 9.1.3 Localization tools
  - 9.1.3.1 Overview
  - 9.1.3.2 Localization tools: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

10. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Guidance Technique

10.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Guidance Technique
- 10.1.1 Fluoroscopy-guided EMB
  - 10.1.1.1 Overview
  - 10.1.1.2 Fluoroscopy-guided EMB: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 10.1.2 Echocardiography-guided EMB
  - 10.1.2.1 Overview
  - 10.1.2.2 Echocardiography-guided EMB: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 10.1.3 Hybrid techniques
  - 10.1.3.1 Overview
  - 10.1.3.2 Hybrid techniques: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

11. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by Application

11.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by Application
- 11.1.1 Transplant rejection monitoring
  - 11.1.1.1 Overview
  - 11.1.1.2 Transplant rejection monitoring: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.2 Myocarditis diagnosis
  - 11.1.2.1 Overview
  - 11.1.2.2 Myocarditis diagnosis: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.3 Cardiomyopathy evaluation
  - 11.1.3.1 Overview
  - 11.1.3.2 Cardiomyopathy evaluation: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.4 Other cardiac pathologies
  - 11.1.4.1 Overview
  - 11.1.4.2 Other cardiac pathologies: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

12. South and Central America Endomyocardial Biopsy Devices Market Revenue Analysis - by End User

12.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis by End User
- 12.1.1 Cardiac centers and hospitals
  - 12.1.1.1 Overview
  - 12.1.1.2 Cardiac centers and hospitals: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 12.1.2 Diagnostic and research institutes
  - 12.1.2.1 Overview
  - 12.1.2.2 Diagnostic and research institutes: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 12.1.3 Academic institutions
  - 12.1.3.1 Overview
  - 12.1.3.2 Academic institutions: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

13. South and Central America Endomyocardial Biopsy Devices Market - Country Analysis

13.1 South and Central America
- 13.1.1 South and Central America Endomyocardial Biopsy Devices Market Forecast and Analysis - by Country
  - 13.1.1.1 Brazil Market
    - 13.1.1.1.1 Brazil: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.1.2 Brazil: South and Central America Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.1.2.1 Product Type
      - 13.1.1.1.2.2 Biopsy Forceps And Catheters
      - 13.1.1.1.2.3 Guidance Systems - Product Type
      - 13.1.1.1.2.4 Accessories
      - 13.1.1.1.2.5 Guidance Technique
      - 13.1.1.1.2.6 Application
      - 13.1.1.1.2.7 End User
  - 13.1.1.2 Argentina Market
    - 13.1.1.2.1 Argentina: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.2.2 Argentina: South and Central America Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.2.2.1 Product Type
      - 13.1.1.2.2.2 Biopsy Forceps And Catheters
      - 13.1.1.2.2.3 Guidance Systems - Product Type
      - 13.1.1.2.2.4 Accessories
      - 13.1.1.2.2.5 Guidance Technique
      - 13.1.1.2.2.6 Application
      - 13.1.1.2.2.7 End User
  - 13.1.1.3 Rest of South and Central America Market
    - 13.1.1.3.1 Rest of South and Central America: South and Central America Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.3.2 Rest of South and Central America: South and Central America Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.3.2.1 Product Type
      - 13.1.1.3.2.2 Biopsy Forceps And Catheters
      - 13.1.1.3.2.3 Guidance Systems - Product Type
      - 13.1.1.3.2.4 Accessories
      - 13.1.1.3.2.5 Guidance Technique
      - 13.1.1.3.2.6 Application
      - 13.1.1.3.2.7 End User

14 Endomyocardial Biopsy Devices Market Industry Landscape

15 - Key Company Profiles

15.1 Terumo Corp
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Argon Medical Devices
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Koninklijke Philips NV
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 GE HealthCare Technologies Inc
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Siemens Healthineers AG
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Cordis Corp
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Scholten Surgical Instruments, Inc.
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Changzhou Lookmed Medical Instrument Co., Ltd.
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 FEHLING INSTRUMENTS GmbH
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 WILDmedical GmbH
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments

16. Appendix

16.1 Glossary
16.2 Research Methodology and Approach
- 16.2.1 Secondary Research
- 16.2.2 Primary Research
- 16.2.3 Market Estimation Approach
  - 16.2.3.1 Supply Side Analysis
  - 16.2.3.2 Demand Side Analysis
- 16.2.4 Research Assumptions and Limitations
- 16.2.5 Currency Conversion
16.3 About The Insight Partners
16.4 Market Intelligence Cloud